| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.97B | 26.07B | 24.98B | 23.29B | 22.54B | 17.58B |
| Gross Profit | 11.87B | 5.69B | 4.03B | 2.99B | 3.66B | 8.61B |
| EBITDA | 5.43B | 5.33B | 3.83B | 2.62B | 3.75B | 3.18B |
| Net Income | 3.44B | 3.37B | 2.30B | 1.32B | 2.45B | 2.07B |
Balance Sheet | ||||||
| Total Assets | 62.86B | 62.87B | 59.53B | 55.98B | 53.74B | 66.35B |
| Cash, Cash Equivalents and Short-Term Investments | 2.40B | 18.92B | 18.90B | 17.94B | 23.85B | 4.12B |
| Total Debt | 4.96B | 5.25B | 5.47B | 5.74B | 5.28B | 6.31B |
| Total Liabilities | 41.59B | 42.03B | 41.38B | 39.50B | 37.61B | 38.20B |
| Stockholders Equity | 21.27B | 20.84B | 18.15B | 16.19B | 15.84B | 15.67B |
Cash Flow | ||||||
| Free Cash Flow | 3.71B | 3.93B | 2.96B | 1.39B | 3.25B | 2.80B |
| Operating Cash Flow | 4.24B | 4.39B | 3.39B | 1.85B | 3.67B | 3.13B |
| Investing Cash Flow | -1.42B | -2.58B | -1.61B | -2.00B | -2.75B | -5.97B |
| Financing Cash Flow | -1.82B | -1.60B | -2.01B | 321.00M | -2.21B | 4.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | C$72.75B | 16.25 | 15.17% | 3.62% | 4.22% | 13.75% | |
76 Outperform | C$52.39B | 19.11 | 11.34% | 3.28% | 7.10% | 0.39% | |
75 Outperform | C$47.89B | 13.96 | 16.93% | 1.86% | 3.57% | 51.86% | |
71 Outperform | C$15.39B | 14.94 | 12.80% | 2.11% | -1.40% | 14.51% | |
69 Neutral | C$8.03B | 20.32 | 9.82% | 0.98% | 24.56% | -10.00% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | C$49.47B | 7.14 | 17.32% | 0.84% | 2.46% | 15.03% |